ArticleInternal medicine (Tokyo, Japan)2018

An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib.

Mitsuo Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.